ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

VERU Veru Inc

1.48
-0.01 (-0.67%)
プレマーケット
最終更新日: 22:24:14
15分遅延
名称 銘柄コード 市場 種別
Veru Inc VERU NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.01 -0.67% 1.48 22:24:14
始値 安値 高値 終値 前日終値
1.49
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0221:30GLOBEVeru to Present at the GLP-1 Based Therapeutics Summit
2024/5/0121:30GLOBEVeru to Report Fiscal 2024 Second Quarter Financial Results..
2024/4/3021:30GLOBEVeru Enrolls First Patients in Phase 2b Clinical Trial of..
2024/4/2521:30GLOBEVeru to Present at the American Association of Clinical..
2024/4/0205:05GLOBEVeru Announces Date of 2024 Annual Meeting of Shareholders
2024/3/2305:05GLOBEVeru Reschedules Annual Meeting of Shareholders
2024/3/1221:00GLOBEVeru Announces the Appointment of Louis Aronne MD as Chief..
2024/2/2809:15GLOBEVeru Announces Notification from Nasdaq Related to Delayed..
2024/2/2022:30GLOBEVeru Announces New Scientific Advisory Board for its..
2024/2/1606:49EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
2024/2/1606:06EDGAR2Form 8-K - Current report
2024/2/1506:32EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/0821:00EDGAR2Form 8-K - Current report
2024/2/0820:30GLOBEVeru Reports Fiscal 2024 First Quarter Financial Highlights
2024/2/0706:27EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/0622:30GLOBEVeru Announces FDA Clearance of IND Application to Initiate..
2024/1/3122:30GLOBEVeru to Present at the Oppenheimer 34th Annual Healthcare..
2024/1/2706:06EDGAR2Form 8-K - Current report
2024/1/2623:02EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2024/1/2623:00EDGAR2Form DEF 14A - Other definitive proxy statements
2024/1/2522:30GLOBEVeru to Report Fiscal 2024 First Quarter Financial Results..
2024/1/0822:30GLOBEVeru Submits IND Application to FDA for the Development of..
2023/12/2706:31EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2023/12/1922:30GLOBEVeru to Host Investor Call on January 4th, 2024 to Discuss..
2023/12/1823:01EDGAR2Form 8-K - Current report
2023/12/1606:04EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/12/1423:00GLOBEVeru Announces Pricing of Public Offering of Common Stock
2023/12/1406:23EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/12/1406:06EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/12/1406:04EDGAR2Form 8-K - Current report
2023/12/1406:01GLOBEVeru Announces Proposed Public Offering of Common Stock
2023/12/0906:02EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2023/12/0904:30EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2023/11/1808:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1807:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1807:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1807:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1606:54EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
2023/11/1606:50EDGAR2Form 8-K - Current report
2023/10/0421:30GLOBEVeru Reports Muscle Data from 5 Clinical Studies of..
2023/10/0306:23EDGAR2Form 8-K - Current report
2023/9/2905:22EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2023/9/2621:30GLOBEVeru Reaches Agreement with FDA on New Phase 3 Clinical..
2023/9/2021:30GLOBEVeru to Participate in Fireside Chat at the 2023 Cantor..
2023/9/1120:00EDGAR2Form 8-K - Current report
2023/9/1120:00GLOBEVeru Reports Clinical Data from the Discontinued ARTEST..
2023/8/3021:30GLOBEVeru to Present at the H.C. Wainwright 25th Annual Global..
2023/8/1101:53EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/1020:00EDGAR2Form 8-K - Current report
2023/8/1019:30GLOBEVeru Reports Fiscal 2023 Third Quarter Financial Results

最近閲覧した銘柄

Delayed Upgrade Clock